FR23C1037I1 - Compositions à base de mycoplasma bovis - Google Patents

Compositions à base de mycoplasma bovis

Info

Publication number
FR23C1037I1
FR23C1037I1 FR23C1037C FR23C1037C FR23C1037I1 FR 23C1037 I1 FR23C1037 I1 FR 23C1037I1 FR 23C1037 C FR23C1037 C FR 23C1037C FR 23C1037 C FR23C1037 C FR 23C1037C FR 23C1037 I1 FR23C1037 I1 FR 23C1037I1
Authority
FR
France
Prior art keywords
compositions based
mycoplasma bovis
bovis
mycoplasma
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR23C1037C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Zoetis Services LLC
Original Assignee
University of Melbourne
Zoetis Services LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Melbourne, Zoetis Services LLC filed Critical University of Melbourne
Publication of FR23C1037I1 publication Critical patent/FR23C1037I1/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma
FR23C1037C 2015-08-14 2023-10-18 Compositions à base de mycoplasma bovis Active FR23C1037I1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562205125P 2015-08-14 2015-08-14
PCT/US2016/046572 WO2017030901A1 (fr) 2015-08-14 2016-08-11 Compositions à base de mycoplasma bovis

Publications (1)

Publication Number Publication Date
FR23C1037I1 true FR23C1037I1 (fr) 2023-12-08

Family

ID=56800367

Family Applications (1)

Application Number Title Priority Date Filing Date
FR23C1037C Active FR23C1037I1 (fr) 2015-08-14 2023-10-18 Compositions à base de mycoplasma bovis

Country Status (22)

Country Link
US (2) US11389518B2 (fr)
EP (2) EP4137152A1 (fr)
JP (1) JP6675484B2 (fr)
CN (3) CN115141772A (fr)
AU (2) AU2016307935B2 (fr)
BR (1) BR112018002919B1 (fr)
CA (1) CA2995101A1 (fr)
DK (1) DK3334454T3 (fr)
ES (1) ES2933623T3 (fr)
FI (1) FI3334454T3 (fr)
FR (1) FR23C1037I1 (fr)
HK (1) HK1251478A1 (fr)
HR (1) HRP20221440T1 (fr)
HU (2) HUE060545T2 (fr)
LT (1) LT3334454T (fr)
MX (1) MX2018001841A (fr)
NL (1) NL301244I2 (fr)
PL (1) PL3334454T3 (fr)
PT (1) PT3334454T (fr)
SI (1) SI3334454T1 (fr)
WO (1) WO2017030901A1 (fr)
ZA (1) ZA201800956B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN111471695A (zh) * 2020-05-11 2020-07-31 吉林农业大学 牛支原体免疫磁珠的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5174993A (en) 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
KR100242671B1 (ko) 1991-03-07 2000-03-02 고돈 에릭 유전학적으로 처리한 백신 균주
IL101715A (en) 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
JPH07507854A (ja) 1991-12-23 1995-08-31 ツォッヒェ，ミヒャエル 油除去装置を備えたエンジン
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
DK0886679T3 (da) 1996-02-28 2007-09-24 Bayer Healthcare Ag Parakoppevira indeholdende fremmed DNA, fremstilling heraf og deres anvendelse i vacciner
WO1998017799A1 (fr) 1996-10-23 1998-04-30 The Trustees Of The University Of Pennsylvania Immunotherapie et vaccins perfectionnes
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
EP1078093B1 (fr) 1998-02-27 2011-06-08 The Trustees of The University of Pennsylvania Vaccins, agents d'immunotherapie et procedes pour leur utilisation
BR9908754A (pt) 1998-03-13 2000-11-28 American Home Prod Composições liofilizada e lìquida de polinucleotìdeo e farmacêutica, processos para tratar um paciente mamìfero e para preparar uma composição liofilizada de polinucleotìdeo, produto liofilizado de polinucleotìdeo, e, processo para liofilizar uma composição de polinucleotìdeo
EP1117435B1 (fr) 1998-09-30 2007-11-14 Wyeth Holdings Corporation Holotoxine mutante du cholera utilisee comme adjuvant
AU782508B2 (en) 1999-11-08 2005-08-04 Biomune Vaccines for mycoplasma bovis and methods of use
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
GB0110851D0 (en) 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
EP1404368B1 (fr) 2001-06-07 2009-12-09 Wyeth Holdings Corporation Formes mutantes de l'holotoxine du cholera en tant qu'adjuvant
JP2005508143A (ja) 2001-06-07 2005-03-31 ワイス・ホールデイングス・コーポレーシヨン アジュバントとしてのコレラホロトキシンの突然変異形
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
EP1601333B1 (fr) 2003-02-20 2013-01-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Nouveaux sites d'insertion dans des vecteurs de variole
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
NZ589981A (en) 2008-07-03 2012-11-30 Univ Iowa State Res Found Inc Cattle vaccines comprising a disrupted M. bovis bacterium
KR20110089260A (ko) * 2008-10-31 2011-08-05 베링거잉겔하임베트메디카인코퍼레이티드 다가 백신 조성물에서 마이코플라즈마 보비스 유래의 항원을 포함하는 다양한 항원의 용도
JP5753098B2 (ja) * 2009-02-20 2015-07-22 オーストラリアン ポールトリー シーアールシー ピーティーワイ リミテッド 弱毒生ワクチン
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada

Also Published As

Publication number Publication date
EP3334454A1 (fr) 2018-06-20
HRP20221440T1 (hr) 2023-02-03
NL301244I1 (nl) 2023-10-04
WO2017030901A1 (fr) 2017-02-23
PT3334454T (pt) 2022-12-20
AU2022231761A1 (en) 2022-10-06
EP4137152A1 (fr) 2023-02-22
HUS2300032I1 (hu) 2023-10-28
US11389518B2 (en) 2022-07-19
MX2018001841A (es) 2018-08-01
HK1251478A1 (zh) 2019-02-01
BR112018002919A2 (pt) 2018-09-18
AU2016307935B2 (en) 2022-08-18
US20190255166A1 (en) 2019-08-22
LT3334454T (lt) 2022-12-27
JP6675484B2 (ja) 2020-04-01
BR112018002919B1 (pt) 2024-02-27
AU2016307935A1 (en) 2018-02-22
NL301244I2 (nl) 2023-11-01
CN108135989A (zh) 2018-06-08
CN108135989B (zh) 2022-08-09
JP2018523708A (ja) 2018-08-23
PL3334454T3 (pl) 2023-01-30
HUE060545T2 (hu) 2023-03-28
FI3334454T3 (fi) 2023-01-13
DK3334454T3 (da) 2022-11-14
US20220296694A1 (en) 2022-09-22
CA2995101A1 (fr) 2017-02-23
EP3334454B1 (fr) 2022-10-19
ZA201800956B (en) 2018-12-19
ES2933623T3 (es) 2023-02-10
CN115141772A (zh) 2022-10-04
SI3334454T1 (sl) 2023-02-28
CN115141773A (zh) 2022-10-04

Similar Documents

Publication Publication Date Title
MA46458A (fr) Compositions debacillus thuringiensis
BR112017027490A2 (pt) composições à base de petrolato compreendendo biocidas catiônicos
DK3361870T3 (da) Fungicidsammensætninger
MA41976A (fr) Composition lubrifiante ultra-fluide
DK3334726T3 (da) Plinabulinsammensætninger
FR3034100B1 (fr) Composition lubrifiante
DK3250182T3 (da) Dispergible sammensætninger
DK3261653T3 (da) Bacillus subtilis-underart
DK3528902T3 (da) Ringegelsammensætning
FR23C1037I1 (fr) Compositions à base de mycoplasma bovis
DK3377036T3 (da) Rumtemperaturhærdbare sammensætninger
DK3316857T3 (da) Multifasiske sammensætninger
DK3229568T3 (da) Kabinet
DK3393254T3 (da) Sammensætning
DK3609464T3 (da) Xanthohumolbaserede sammensætninger
BR112016026478A2 (pt) Composição de polímero à base de propileno
DK3528791T3 (da) Dispergible sammensætninger
DK3416502T3 (da) Glykæmisk-reducerende sammensætning
DK3337322T3 (da) Fungicidsammensætninger
BR112017016240A2 (pt) composição
DK3176187T4 (da) Hærdbar polymersammensætning
DK3393503T3 (da) Sammensætninger
FR3057010B1 (fr) Volet coulissant
DK3322295T3 (da) Sammensætning
DK3410854T3 (da) Mikrobicid sammensætning